Synthetic Biologics, Inc. (NYSEMKT:SYN)

CAPS Rating: 2 out of 5

A development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and fibrotic diseases.

Recs

0
Player Avatar pchop123 (79.56) Submitted: 12/31/2012 9:27:47 AM : Underperform Start Price: $1.61 SYN Score: -4.69

dog

Featured Broker Partners


Advertisement